UCB BIOPHARMA

Organisation Private Company Belgium
BRUXELLES , Belgium

UCB BIOPHARMA

35
Projects
0
Interests Submitted
937666409
PIC
937666409
Reference

Projects

TASPPI

Targeted small-molecule Stabilisation of Protein-Protein Interactions

H2020 Signed H2020-MSCA-ITN-2015

INSPIRE

INnovation in Safety Pharmacology for Integrated cardiovascular safety assessment to REduce adverse events and late stage drug attrition.

H2020 Signed H2020-MSCA-ITN-2019

ISOTOPICS

ISOTOPIC LABELING FOR DRUG INNOVATION

H2020 Signed H2020-MSCA-ITN-2015

EHDEN

European Health Data and Evidence Network

H2020 Signed H2020-JTI-IMI2-2017-12-two-stage

RADAR-CNS

Remote Assessment of Disease and Relapse in Central Nervous System Disorders

H2020 Signed H2020-JTI-IMI2-2015-03-two-stage

DO-IT

Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055

H2020 Signed H2020-JTI-IMI2-2015-07-two-stage

GetReal Initiative

The GetReal Initiative

H2020 Signed H2020-JTI-IMI2-2017-11-single-stage

PARADIGM

Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes.

H2020 Signed H2020-JTI-IMI2-2016-10-two-stage

IDEA-FAST

Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases

H2020 Signed H2020-JTI-IMI2-2018-15-two-stage

Gravitate-Health

Gravitate–Health: Empowering and Equipping Europeans with health information for Active Personal Health Management and Adherence to Treatment

H2020 Signed H2020-JTI-IMI2-2019-18-two-stage

PharmaLedger

PharmaLedger

H2020 Signed H2020-JTI-IMI2-2018-15-two-stage

NeuroDeRisk

Neurotoxicity De-Risking in Preclinical Drug Discovery

H2020 Signed H2020-JTI-IMI2-2017-13-two-stage

EQIPD

European Quality In Preclinical Data

H2020 Signed H2020-JTI-IMI2-2016-09-two-stage

c4c

conect4children (COllaborative Network for European Clinical Trials For Children)

H2020 Signed H2020-JTI-IMI2-2016-10-two-stage

EFOEUPATI

Ensuring the future of EUPATI beyond 2020

H2020 Signed H2020-JTI-IMI2-2017-11-single-stage

EBiSC2

EBiSC2 – A sustainable European Bank for induced pluripotent Stem Cells

H2020 Signed H2020-JTI-IMI2-2017-13-two-stage

READI

Research in Europe and Diversity Inclusion

HORIZON Signed HORIZON-JU-IHI-2023-04-two-stage

Trials@Home

Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials

H2020 Signed H2020-JTI-IMI2-2018-14-two-stage

AutoPiX

IMAGING FOR PATIENT BENEFIT IN ARTHRITIS

HORIZON Signed HORIZON-JU-IHI-2024-07-single-stage

BIGPICTURE

Central Repository for Digital Pathology

H2020 Signed H2020-JTI-IMI2-2019-18-two-stage

Showing first 20 projects. View full list on EC Europa profile.

Main Collaborations

NOVARTIS PHARMA AG (BASEL, CH)
JANSSEN PHARMACEUTICA NV (BEERSE, BE)
PFIZER LIMITED (SANDWICH, UK)
F. HOFFMANN-LA ROCHE AG (BASEL, CH)
SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (GENTILLY, FR)
NOVO NORDISK A/S (BAGSVAERD, DK)
BAYER AKTIENGESELLSCHAFT (LEVERKUSEN, DE)
GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LIMITED (LONDON, UK)
ASTRAZENECA AB (SODERTAELJE, SE)
ABBVIE INC (NORTH CHICAGO IL, US)

Work Programmes

H2020 HORIZON

Additional Information

VAT: BE0543573053
Validation Status: 31042522